John Paulson started to build up the position in Alnylam Pharmaceuticals in Q4 2015 and continued to invest until Q2 2016. Since then they sold 19.3 Thousand shares. The investor sold all their shares in Q1 2017 and doesn't own any shares in Alnylam Pharmaceuticals anymore.